A Comparison of Entecavir and Lamivudine for HBeAg-Positive Chronic Hepatitis B

Authors

Ting-Tsung Chang

Published

March 8, 2006

Abstract

Entecavir is a potent and selective guanosine analogue with significant activity against hepatitis B virus (HBV).

Supporters

Support the authors with ResearchCoin

Journal

New England Journal of Medicine

Topics

DOI

10.1056/nejmoa051285

A Comparison of Entecavir and Lamivudine for HBeAg-Positive Chronic Hepatitis B

Authors

Ting-Tsung Chang

Published

March 8, 2006

Abstract

Entecavir is a potent and selective guanosine analogue with significant activity against hepatitis B virus (HBV).

Supporters

Support the authors with ResearchCoin

Journal

New England Journal of Medicine

Topics

DOI

10.1056/nejmoa051285

Paper

Paper

Paper

Paper

A Comparison of Entecavir and Lamivudine for HBeAg-Positive Chronic Hepatitis B

Abstract

Supporters

Journal

Topics

DOI

A Comparison of Entecavir and Lamivudine for HBeAg-Positive Chronic Hepatitis B

Abstract

Supporters

Journal

Topics

DOI